Key facts
- Oxford Medical Simulation’s last known valuation is $53.2M (Jan 2024).
- It has raised $26.5M; the latest was Later Stage VC ($6.8M) in Mar 2026.
- Notable investors include Salica Investments, ACF Investors, Oxford Innovation Finance, Court Cavendish, Eden Rock Capital Management — 13 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 13 names
- ·Watchlist + deal alerts for Oxford Medical Simulation
- ·The full record, as it builds
Funding rounds
No funding rounds for Oxford Medical Simulation are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Oxford Medical Simulation
Developer of a virtual reality medical simulation platform designed to train healthcare professionals. The company's simulation platform offers scenarios for doctors and nurses where they must manage the patient as in real life, perform investigations, instigate treatment, and interact with their interdisciplinary team against the clock, enabling medical professionals to get access to a customizable, evidence-based, and cost-efficient alternative to traditional simulation.
- Sector
- Information Technology
- HQ
- London, United Kingdom
- Founded
- 2017
- Employees
- 118
- Website
- oxfordmedicalsimulation.com/
- Ownership
- Privately Held (backing)
Oxford Medical Simulation doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Oxford Medical Simulation shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Oxford Medical Simulation in its N-PORT filings yet. We sweep new filings monthly.